OPK
OPKO Health, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$1.65
+2.17%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
28.4x
Market Cap
$1.23B
MomentumView details →
1D Return
+2.17%
YTD Return
+28.97%
RSI (14)
65.4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
28.4x
Market Cap
$1.23B
RSI (14)
65.4
MomentumView details →
1D Return
+2.17%
YTD Return
+28.97%
SummaryUpdated Jun 1, 2026
OPKO Health, Inc. (NASDAQ:OPK) is a diversified healthcare company founded in 1991 and headquartered in Miami, Florida. The company went public in 1995 and operates through two primary business segments: diagnostics and pharmaceuticals. OPKO has evolved from a traditional pharmaceutical company into a broader healthcare enterprise that combines laboratory testing services with drug development and commercialization. The company operates internationally across the United States, Ireland, Chile, Spain, Israel, and Mexico, serving healthcare providers, patients, and pharmaceutical partners through its integrated platform of diagnostic services and therapeutic products.
Similar companies
Latest newsMore news →
OPKO Health secured $125 million in financing against its mazdutide royalties, obtaining non-dilutive capital while retaining longer-term royalty upside.17d agoOPKO Health issued $125 million in notes to HealthCare Royalty, secured by royalty interests in Mazdutide, to raise non-dilutive capital.22d agoCocrystal Pharma announced a $5 million private placement with OPKO Health, which increased its investment in the company.32d ago